Assets in USD of Lexeo Therapeutics, Inc. from Q4 2022 to Q3 2025

Taxonomy & unit: us-gaap: USD
Description: Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.
Summary: Lexeo Therapeutics, Inc. quarterly Assets history and growth rate from Q4 2022 to Q3 2025.
Lexeo Therapeutics, Inc. Assets for the quarter ending September 30, 2025 was $144M, a 17.3% decline year-over-year.

Assets, Quarterly (USD)

Assets, YoY Quarterly Growth (%)

Lexeo Therapeutics, Inc. Quarterly Assets (USD)

Period	Value	YoY Chg	Change %	Date	Report	Filed
Q3 2025	$144M	-$30M	-17.3%	Sep 30, 2025	10-Q	2025-11-05
Q2 2025	$176M	-$15.9M	-8.3%	Jun 30, 2025	10-Q	2025-08-14
Q1 2025	$126M	-$87.5M	-41%	Mar 31, 2025	10-Q	2025-05-12
Q4 2024	$147M	+$7.14M	+5.1%	Dec 31, 2024	10-Q	2025-11-05
Q3 2024	$174M	+$119M	+218%	Sep 30, 2024	10-Q	2024-11-13
Q2 2024	$192M			Jun 30, 2024	10-Q	2024-08-12
Q1 2024	$213M			Mar 31, 2024	10-Q	2024-05-09
Q4 2023	$140M	+$42.7M	+44%	Dec 31, 2023	10-K	2025-03-24
Q3 2023	$54.7M			Sep 30, 2023	10-Q	2023-12-11
Q4 2022	$97.1M			Dec 31, 2022	10-K	2024-03-11

* An asterisk sign (*) next to the value indicates that the value is likely invalid.